unknown
Stage
2
Investors
About
Ikena Oncology develops targeted therapies for cancer treatment, focusing on identifying and inhibiting novel kinases that drive tumor growth and drug resistance.
Explore Ikena Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.